Aclidinium Bromide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Aclidinium Bromide;   Drug: Formoterol Fumarate;   Drug: PlaceboSponsors:   Forest Laboratories;    Almirall, S.A.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2012 Category: Research Source Type: clinical trials